15^th World Heart Congress

Cardiovascular pharmacology

Cardiovascular pharmacology plays a central role in preventing, treating, and managing cardiovascular diseases through evidence-based medical therapies. Continuous advances in pharmacological research have introduced innovative medications that improve survival, reduce hospitalizations, and enhance quality of life for patients with heart failure, coronary artery disease, hypertension, arrhythmias, and thromboembolic disorders. Emerging therapeutic approaches increasingly incorporate pharmacogenomics, precision medicine, novel biologic agents, lipid-lowering therapies, anticoagulants, and anti-inflammatory drugs to optimize treatment outcomes. Understanding drug mechanisms, safety profiles, interactions, and individualized dosing remains essential for effective cardiovascular care.

This session will provide comprehensive insights into the latest developments in cardiovascular pharmacology, including heart failure therapeutics, antiplatelet and anticoagulant therapy, lipid-lowering agents, antihypertensive medications, antiarrhythmic drugs, precision pharmacotherapy, and emerging cardiovascular drug development. Experts will present findings from clinical trials, translational research, pharmacogenomic studies, and real-world evidence supporting innovative treatment strategies. Discussions will emphasize medication safety, personalized prescribing, evidence-based clinical practice, and future directions in cardiovascular drug discovery aimed at improving patient outcomes across diverse cardiovascular conditions.